ZINPLAVA (Formely known Bezlotoxumab MSD))

Licence status
Authorised: 18/01/2017
Active substances
Bezlotoxumab
Dosage Form
Concentrate for solution for infusion
Licence number
EU/1/16/1156/001
Licence holder
Merck Sharp & Dohme BV

Product documents

Licence information

ATC code
J06BB Specific immunoglobulins, J06BB21 Bexlooxumab
Route of supply
Product subject to prescription which may not be renewed (A)
Place of sale
Supply through pharmacies only
Marketing availability
Unknown
Advertising conditions
Advertising to healthcare professionals only
Licence issued
18/01/2017

Stay updated: document advice

The information and documents on this page are subject to frequent updates. We recommend you do not retain saved or printed versions of them. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie